Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Annual Revenue (¥)
SNBL revenue was ¥17.75 b in FY, 2022
| FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | |
|---|---|---|---|---|---|
| Revenue | ¥16.6 b | ¥15.66 b | ¥14.56 b | ¥15.11 b | ¥17.75 b |
Revenue Breakdown
Business Segment
SNBL revenue breakdown by business segment: 5.4% from OTHER NONDISCLOSED and 94.6% from OTHER SCHOOLS
| FY, 2022 | FY, 2021 | FY, 2020 | FY, 2019 | FY, 2018 | |
|---|---|---|---|---|---|
| PRECLINICAL RESEARCH OPERATION | ¥13.12 m | ¥13.75 m | ¥13.98 m | ||
| CLINICAL PHARMACOLOGY OPERATION | ¥703.17 k | ¥1.17 m | ¥1.74 m | ||
| OTHER NONDISCLOSED | ¥968.97 k | ¥503.87 k | ¥150.98 k | ¥108.39 k | ¥108.46 k |
| ELIMINATIONS | (¥844.7 k) | (¥466.6 k) | (¥416.35 k) | (¥340.1 k) | (¥211.72 k) |
| RESEARCH & TESTING SVC | ¥12.86 k | ¥12.24 k | ¥1.2 k | ¥11.74 k | ¥39.69 k |
| MEDIPOLIS BUSINESS | ¥563.5 k | ¥552.18 k | ¥1 m | ¥962.88 k | ¥947.36 k |
| OTHER SCHOOLS | ¥17.05 m | ¥14.51 m |
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.